OTX1 and OTX2 Genes in Medulloblastoma

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
WORLD NEUROSURGERY, v.127, p.E58-E64, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To study the prevalence of OTX1 and OTX2 gene expression in 60 medulloblastoma specimen samples and to establish correlations between gene expression and clinical and histopathological aspects. METHODS: We performed a retrospective analysis of 60 patients with a diagnosis of medulloblastoma at the Clinicas Hospital of the School of Medicine, University of Sao Paulo, and the Cancer Hospital of Barretos. We created a database of the 60 patients containing information on the gene expression of OTX1 and OTX2 (obtained using realtime polymerase chain reaction) and clinical and epidemiological data. Statistical tests were performed to verify potential correlations of clinicopathological data and follow-up aspects with gene expression. RESULTS: The OTX1 gene was expressed in 52% of the study population. Expression varied with age (higher in adults), location (predominantly by hemisphere), and histological type (desmoplastic). The OTX2 gene was expressed in 62% of the study population. Expression varied with age (higher in younger age groups), location (predominantly vermis), and histological type (classic and anaplastic). A statistical correlation between OTX2 gene expression and the development of leptomeningeal metastases was observed. CONCLUSIONS: The relative expression of OTX1 and OTX2 was dependent on patient age, tumor location, and histological variant. In addition, OTX2 expression might be a predictive factor for leptomeningeal metastases of medulloblastoma. The OTX pathway should be consider as an important venue for medulloblastomas development.
Palavras-chave
Classic, Desmoplastic, Medulloblastoma, OTX1 gene, OTX2 gene
Referências
  1. Abacioglu U, 2002, INT J RADIAT ONCOL, V54, P855, DOI 10.1016/S0360-3016(02)02986-3
  2. Acampora D, 1997, DEVELOPMENT, V124, P3639
  3. Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331
  4. Ajeawung NF, 2012, CLIN INVEST MED, V35, pE246
  5. Akay KM, 2004, PEDIATR NEUROSURG, V40, P220, DOI 10.1159/000082295
  6. Albright AL, 1996, NEUROSURGERY, V38, P265, DOI 10.1097/00006123-199602000-00007
  7. Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740
  8. Bai RY, 2010, NEURO-ONCOLOGY, V12, P655, DOI 10.1093/neuonc/nop062
  9. Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134
  10. Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2
  11. Boncinelli E, 2001, TRENDS GENET, V17, P633, DOI 10.1016/S0168-9525(01)02418-0
  12. Boon K, 2005, CANCER RES, V65, P703
  13. Boulay G, 2017, CANCER DISCOV, V7, P288, DOI 10.1158/2159-8290.CD-16-0844
  14. BOURGOUIN PM, 1992, AM J ROENTGENOL, V159, P609, DOI 10.2214/ajr.159.3.1503035
  15. Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229
  16. Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546
  17. Chang Q, 2007, J NEURO-ONCOL, V84, P263, DOI 10.1007/s11060-007-9380-9
  18. Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0
  19. Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007
  20. de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a
  21. Di CH, 2005, CANCER RES, V65, P919
  22. Dubuc AM, 2012, ACTA NEUROPATHOL, V123, P485, DOI 10.1007/s00401-012-0959-7
  23. Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189
  24. Fiorilli P, 2008, LAB INVEST, V88, P1143, DOI 10.1038/labinvest.2008.89
  25. Gumireddy K, 2003, CLIN CANCER RES, V9, P4052
  26. Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904
  27. Han C, 2005, MOL CELL, V17, P321, DOI 10.1016/j.molcel.2005.01.009
  28. Hinman VF, 2000, DEV GENES EVOL, V210, P129, DOI 10.1007/s004270050019
  29. Ho DM, 2002, CANCER, V95, P2578
  30. Ho DMT, 2002, CANCER, V95, P2577, DOI 10.1002/cncr.11003
  31. Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268
  32. Insan MB, 2014, MINI-REV MED CHEM, V14, P20, DOI 10.2174/13895575113136660107
  33. Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284
  34. Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7
  35. Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570
  36. Kobayashi T, 2010, DEV GROWTH DIFFER, V52, P351, DOI 10.1111/j.1440-169X.2010.01170.x
  37. Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8
  38. Kortmann R D, 2003, Forum (Genova), V13, P99
  39. Li KKW, 2013, INT J CLIN EXP PATHO, V6, P1211
  40. Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
  41. Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
  42. Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83
  43. Min HS, 2006, ACTA NEUROPATHOL, V112, P13, DOI 10.1007/s00401-006-0073-9
  44. Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549
  45. Northcott PA, 2012, EXPERT REV NEUROTHER, V12, P871, DOI [10.1586/ERN.12.66, 10.1586/ern.12.66]
  46. Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327
  47. Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78
  48. Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821
  49. Omodei D, 2009, AM J PATHOL, V175, P2609, DOI 10.2353/ajpath.2009.090542
  50. Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2
  51. Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213
  52. Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053
  53. Salsano E, 2007, NEURO-ONCOLOGY, V9, P298, DOI 10.1215/15228517-2007-014
  54. Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0
  55. SZYMAS J, 1987, CHILD NERV SYST, V3, P74, DOI 10.1007/BF00271127
  56. Wortham M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107156
  57. Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192
  58. Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052